SciELO - Scientific Electronic Library Online

 
vol.38 número3Imerslund-Gräsbeck Syndrome: Clinical CaseIntestinal Obstruction Secondary to Gallstone Ileus in a Patient with Cholangitis: Case Report índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista colombiana de Gastroenterología

versão impressa ISSN 0120-9957versão On-line ISSN 2500-7440

Rev. colomb. Gastroenterol. vol.38 no.3 Bogotá jul./set. 2023  Epub 18-Jan-2024

https://doi.org/10.22516/25007440.947 

Case report

Primary Signet Ring Cell Carcinoma of the Duodenum: Case Report

Judith Ruiz-Barrios1 
http://orcid.org/0000-0003-1781-7298

Hernán Rodríguez-Arrieta1 
http://orcid.org/0000-0003-4903-9187

Yennifer Diaz-Montes2 
http://orcid.org/0000-0002-3070-1495

1Physician, Epidemiologist, Universidad Cooperativa de Colombia. University teaching specialist, Universidad del Magdalena. Cartagena, Colombia.

2Nurse, full-time professor, Nursing School, Universidad Cooperativa de Colombia. MS in Public Health, Public Health Department, Universidad del Norte. University teaching specialist, Universidad del Magdalena. Santa Marta, Colombia.


Abstract

Introduction:

Primary carcinoma of the duodenum is an infrequent malignancy; it represents 0.3-0.5% of all carcinomas of the GI tract and 33-45% of all carcinomas of the small intestine.

Clinical case:

A 57-year-old female patient with nonspecific GI symptoms and unintentional weight loss was diagnosed with diffuse, infiltrating, and ulcerated adenocarcinoma in the duodenum. Surgical management with duodenopancreatectomy was considered; however, it could not be performed due to deteriorating nutritional status. She later died due to abdominal sepsis.

Conclusion:

The clinical manifestations of adenocarcinoma of the duodenum are variable and nonspecific. It is a challenge to make an early diagnosis. We recommend considering the diagnostic possibility in patients with nausea, emesis, abdominal pain, and weight loss, which requires esophagogastroduodenoscopy and histological and immunohistochemical confirmation.

Keywords: Neoplasm; duodenum; mucinous adenocarcinoma

Resumen

Introducción:

el carcinoma primario de duodeno es una neoplasia maligna infrecuente; representa el 0,3%-0,5% de todos los carcinomas del tracto gastrointestinal y el 33%-45% de todos los carcinomas de intestino delgado.

Caso clínico:

paciente de sexo femenino de 57 años, con sintomatología gastrointestinal inespecífica y pérdida de peso no intencional a quien se le diagnosticó un adenocarcinoma difuso, infiltrante y ulcerado en el duodeno. Se planteó el manejo quirúrgico con duodenopancreatectomía; sin embargo, no pudo realizarse debido al deterioro del estado nutricional y posteriormente falleció como consecuencia de una sepsis abdominal.

Conclusión:

las manifestaciones clínicas del adenocarcinoma de duodeno son variables e inespecíficas, es un reto realizar un diagnóstico precoz. Se recomienda considerar la posibilidad diagnóstica en pacientes con síntomas de náuseas, emesis, dolor abdominal y pérdida de peso, que requiere la realización de esofagogastroduodenoscopia y confirmación histológica e inmunohistoquímica.

Palabras clave: Neoplasia; duodeno; adenocarcinoma mucinoso

Introduction

Cancer is one of the leading causes of death worldwide. In 2020, 10 million deaths were attributed to this disease, while in Colombia, it is among the first three causes of mortality. The types of cancer that cause the greatest number of deaths are lung, liver, stomach, colon, and breast. However, there are other types of cancer in rare locations that pose a diagnostic challenge and are mostly discovered late by a process of elimination or as an incidental or post-mortem finding1.

Among these rare neoplastic pathologies is primary adenocarcinoma of the duodenum, representing 0.3%-0.5% of all gastrointestinal tract carcinomas and 33%-45% of all small intestine carcinomas2. The difficulty in diagnosing small intestine tumors early can be explained by the rarity of this entity and the nonspecific and variable nature of the signs and symptoms that occur. Therefore, a delay in diagnosis is expected, which decreases the possibility of curative treatment and patient survival3,4.

This case report aims to describe the clinical-epidemiological characteristics of primary duodenal carcinoma with signet ring cells in an adult woman.

Case report

We present the case of a 57-year-old female patient with a history of high blood pressure, hysterectomy for carcinoma in situ of the cervix at age 47, resection of basal cell carcinoma on the face at age 51, and no harmful habits such as smoking or alcohol or psychoactive substance use, and without significant family history. She was admitted to the hospital for a 2-year history of intermittent abdominal pain in the right upper quadrant, with an intensity of 6/10 on the pain analog scale, which partially improved with common analgesics but was exacerbated with some foods and got worse in the last 2 months. It was associated with abdominal distention, changes in bowel habits, and unintentional weight loss of approximately 4 kg.

The patient had an initial diagnostic impression of irritable bowel syndrome, for which she received medical treatment and dietary changes without improvement. Given the persistence of the condition, a total abdominal ultrasound was performed, which showed a lesion at the level of the upper limit of the right and left lobes. An image measuring 7.45 x 4.99 cm was seen with irregular contours of mixed echogenicity bordering with the gallbladder, intra- and extrahepatic bile duct without dilation, gallbladder with poor filling, thickened walls of 0.66 cm, edematous and a hyperechoic image of 0.57 cm, which produces a solid posterior shadow cone corresponding to a stone. The rest of the examination was normal, with diagnostic impressions of cholelithiasis, cholecystitis, and liver abscess.

Upon admission, she was clinically stable, with pain on palpation in the right hypochondrium and, in the epigastrium, a mass of hard consistency with defined edges and immobile in the right hypochondrium could be palpated. A dynamic computed axial tomography (CT) of the liver was requested. Figure 1 shows a hypodense image at the lower edge of the right lobe towards segment V of the liver, which heterogeneously captured the intravenous iodinated contrast, possibly due to a solid neoplastic-type lesion in the liver parenchyma. However, it is impossible to characterize this lesion since the gallbladder appears small and has thick walls without showing a stone. The bile and extrahepatic ducts were found normal, and a small amount of fluid was noted in the hepatorenal space. Laboratory tests showed moderate microcytic and hypochromic anemia, hypoalbuminemia, and markedly elevated CA 19.9 antigen.

Figure 1 Dynamic liver CT. Image owned by the authors. 

At this time, gallbladder cancer was suspected, so a liver biopsy and diagnostic laparoscopy were scheduled. During this procedure, a retroperitoneal mass was found, from which a biopsy was taken, and adhesions were observed in the gallbladder, omentum, and small and large intestine. An endoscopy of the upper GI tract was requested in the operating room (Figure 2), which revealed a bulbar exophytic lesion that occupied 30% of the circumference, non-obstructive, friable, and mamelonated. At the same time, the second duodenal portion was found to be normal. The biopsy report (Figure 3) showed findings compatible with diffuse, infiltrative, and ulcerated adenocarcinoma, while the biopsy of the retroperitoneal lesion showed fibroadipose tissue of the usual morphology free of tumor.

Figure 2 Esophagogastroduodenoscopy. Images owned by the authors. 

Figure 3 Biopsy of duodenal bulb lesion. Image owned by the authors. 

Immunohistochemistry of an endoscopic biopsy of the duodenal lesion was performed, which reported involvement of mucinous carcinoma with signet ring cells and reactivity in the problem cells to CKAE1/AE3, CK20, and CDX-2. The patient was referred to oncology for neoadjuvant treatment; a T3N0M0 staging was performed. It was determined that since it is a rare pathology, there are no defined schemes for metastasis or neoadjuvant therapy, suggesting that a surgical procedure be performed as soon as possible.

At a medical meeting, the oncological gastrointestinal surgery service decided to perform a pancreaticoduodenectomy. However, given the poor nutritional status and hypoalbuminemia, it was decided to provide nutritional support, which was unsuccessful. During that time, there was deterioration in the patient. In a new evaluation, it was found that the size of the tumor now occupied 50% of the circumference involving the first and second portion of the duodenum and extended through the retroperitoneal region through the gastrocolic ligament, with firm adhesions to the liver at the greater curvature and the hepatic and colon angle, in addition to a progression of descent albumin at 1.7 g/dL and weight loss of 17 kg. At this point, it was considered an unresectable tumor, so the medical board decided not to perform curative surgical treatment because the risks were greater than the benefits of surgery. She died 2 months later as a result of abdominal sepsis that produced septic shock 8 months after diagnosis.

Discussion

Malignant duodenal tumors are a rare disease, reflected in the small number of cases reported worldwide5-11. Its infrequency may be justified by possible defense mechanisms of this portion of the small intestine, the speed with which the bolus passes through the duodenum, the secretions that reduce the exposure time of the mucosa and epithelium to different carcinogens, and the relative duodenal sterility, among other protective factors of the intestinal wall3.

The factors that increase the risk of suffering from the disease have not been clarified; some authors have proposed the relationship between the appearance of adenocarcinoma and a previous adenoma, following the evolution already described in colorectal cancer5,6. Adenocarcinoma is most frequently located in the second portion of the duodenum, followed by the third and fourth portions. However, in the case described, the tumor lesion was found in the first portion3-5.

The case presented is an adult woman, although, in the reported literature, this disease is more common in men between 50 and 60 years old5-8. In turn, two of the patients who were part of the series of cases reported by Marcos et al. had a history of cervical cancer, as in our case. Still, it is not possible to establish a causal relationship8.

The small number of patients in the case series in the literature limits the establishment of diagnostic criteria, taking into account that the predominant symptoms are nonspecific and variable, and the typical triad is hyporexia, vomiting, and weight loss. Other symptoms are abdominal pain, obstruction, jaundice when located in the periampullary region, gastrointestinal bleeding, and perforation2,6,9. Ortiz et al. described a condition consisting of nausea, postprandial fullness, and vomiting10. Moreno-Loaiza described weight loss and bleeding as the most frequent symptoms11. In the case presented in this study, the patient presented with symptoms of abdominal pain, nausea, hyporexia, and weight loss, which coincides with the conditions described by Ramia et al.5, Peño Muñoz et al.6, and Chung et al.2. On the other hand, signet ring cells in the duodenal bulb are not a common finding and their presence could be explained as heterotopic gastric mucosa. Authors have proposed that it could be due to metaplasia upon exposure to intraluminal hydrochloric acid, which can be a hypothesis about the pathophysiology of this entity6,8,12.

The diagnosis is made by directly observing the lesion through esophagogastroduodenoscopy, biopsy, and immunohistochemistry studies. Thus, early performance of upper GI tract endoscopy is of utmost importance in patients with clinical symptoms of abdominal pain, weight loss, and abdominal mass. Surgical treatment is the only curative therapeutic option successful when an early diagnosis is made10. There is insufficient evidence about the usefulness of chemotherapy as a treatment for this type of neoplasia. However, the choice in most cases described so far has been 5-fluorouracil due to its known effectiveness in colon and gastric cancer5.

Conclusion

Duodenal carcinoma is a diagnostic challenge due to its rarity and the nonspecific and variable nature of its clinical manifestations. It is advisable to consider this entity in patients with nausea, emesis, abdominal pain, and weight loss symptoms and confirm the diagnosis by performing upper GI tract endoscopy, histological study, and immunohistochemistry. Late discovery of the disease decreases the possibility of curative treatment and patient survival. This article is a reference framework for future research, improvement in clinician decision-making, and knowledge of the academic community.

Referencias

1. Rivillas García JC, Huertas Quintero JA, Moreno Zapata MY, Forero Ballesteros LC, Moreno Chaves TC, Vera Rey AM. Observatorio Nacional de Cáncer. Guía metodológica. Colombia: Instituto Nacional de Cancerología, Ministerio de Salud y Protección Social; 2018 [consultado el día 19 de mayo de 2022]. Disponible en: Disponible en: https:// www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/ RIDE/VS/ED/GCFI/guia-ross-cancer.pdfLinks ]

2. Chung WC, Paik CN, Jung SH, Lee K, Kim SW. Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma. Rev Cuba Cirugía. 2011;50(1):363-87. https://doi.org/10.3904/kjim.2011.26.1.34Links ]

3. Casillas Guzmán GB. Anatomía y fisiología del intestino delgado. En: León Fraga J (editor). Gastroenterología. 1.a edición. México: McGraw-Hill; 2012. p. 206-210. [ Links ]

4. Overman MJ, Kunitake H. Epidemiology, clinical fea- tures, and types of small bowel neoplasms [Internet]. UpToDate; 2023 [consultado el día 20 de mayo de 2022]. Disponible en: Disponible en: https://www. uptodate.com/contents/epidemiology-clinical-features- and-types-of-small-bowel-neoplasms?search=small%20 bowel%20tumour&source=search_ result&selectedTitle=1~97&usage_type=default&display_ rank=1#H5806055Links ]

5. Ramia JM, Villar J, Palomeque A, Muffak K, Mansilla A, Garrote D, et al. Adenocarcinoma de duodeno. Cir Esp. 2005;77(4):208-12. https://doi.org/10.1016/S0009-739X(05)70839-3Links ]

6. Peño Muñoz L, Plana Campos L, Ferrer Barceló L, Sanchís Artero L, Larrey Ruiz L, Núñez Martínez P, et al. Adenocarcinoma duodenal: un diagnóstico poco frecuente. Rev Gastroenterol Peru. 2016;36(2):172-4. [ Links ]

7. Jiménez-Fuertes M, Ruíz-Tóvar J, Díaz-García G, Durán-Poveda M. Adenocarcinoma de la tercera porción duodenal moderadamente diferenciado. Cirugía y Cirujanos. 2017;85(1):76-9. https://doi.org/10.1016/j.circir.2015.11.005Links ]

8. Marcos ER, Frisancho O, Yàbar A. Neoplasia maligna duodenal: Perfil clínico-patológico. Rev Gastroenterol Peru. 2003;23:99-106. [ Links ]

9. Marín J, Osorio M, Arango A, Ángel A, López G, Mejía A. Adenocarcinoma primario del duodeno. Rev Colomb Cir. 1994;9(2):72-6. [ Links ]

10. Ortiz CM, Marco González Martínez FSL, Castro FH. Adenocarcinoma primario de la tercera y cuarta porción del duodeno. Descripción de un caso. Cir Gen. 2003;25(4):338-41. [ Links ]

11. Moreno Loaiza Ó, Neira Rojas D. Primary duodenal adenocarcinoma: case report of an infrequent tumor. Medwave. 2013;13(09):e5821-e5821. https://doi.org/10.5867/medwave.2013.09.5821Links ]

12. Han SL, Cheng J, Zhou HZ, Zeng QQ, Lan SH. The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer. 2010;41(4):243-7. https://doi.org/10.1007/s12029-010-9160-1Links ]

Citation: Ruiz-Barrios J, Rodríguez-Arrieta H, Diaz-Montes Y. Primary Signet Ring Cell Carcinoma of the Duodenum: Case Report. Revista. colomb. Gastroenterol. 2023;38(3):355-359. https://doi.org/10.22516/25007440.947

Received: July 26, 2022; Accepted: October 06, 2022

*Correspondence: Judith Ruiz Barrios. judith.ruizb@campusucc.edu.co

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License